Kumbha Pharmaceuticals Private Limited
About Kumbha Pharmaceuticals Private Limited
Data last updated:
Kumbha Pharmaceuticals Private Limited was a private limited company based in Mumbai, Maharashtra, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the diversified business activities segment of the business services sector. It was incorporated on 23 May 2018.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2018PTC309816. Its GSTIN is 27AAHCK1231D1Z0 (Maharashtra).
The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Sharad Baburao Khaire and Smita Santosh Dhumal.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office was at D 2403 Ashtavinayak Co – Op Hsg Soc Bldg 58/D New Mhada Tower Opp Ekta Nagar, Mumbai, Maharashtra, India – 400067.
Company details
Contact details
Kumbha Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressD 2403 Ashtavinayak Co – Op Hsg Soc Bldg 58/D New Mhada Tower Opp Ekta Nagar, Mumbai, Maharashtra, India – 400067
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
To see the full contact details of Kumbha Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Kumbha Pharmaceuticals Private Limited
FY 2022 filings availableKumbha Pharmaceuticals Private Limited reported revenue of ₹210 (down 100% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 94% over three years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ₹210 | |||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ||||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ||||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Kumbha Pharmaceuticals Private Limited, buy the company report.
Board of directors of Kumbha Pharmaceuticals Private Limited
Kumbha Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sharad Baburao Khaire | Director | 23 May 2018 | 8 Years 5 Months | As last reported |
| Smita Santosh Dhumal | Director | 23 May 2018 | 8 Years 5 Months | As last reported |
Peer comparison
Kumbha Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ziveli Pharmaceuticals Private Limited | ₹325 (FY 2023) | Chennai, Tamil Nadu, India | ||||
| Adiuvo Pharmaceuticals Private Limited | ₹285 (FY 2025) | 6.0% | Mumbai, Maharashtra, India | |||
| Everhale Pharmaceuticals Private Limited | ₹275 (FY 2022) | 175.0% | Mumbai, Maharashtra, India | |||
| Kalpshri Pharmaceuticals Private Limited | ₹273 (FY 2025) | -100.0% | Noida, Uttar Pradesh, India | |||
| Benncare Pharmaceuticals Private Limited | ₹251 (FY 2019) | -95.0% | Cuttack, Odisha, India | |||
| Kumbha Pharmaceuticals Private Limitedthis company | ₹210 (FY 2022) | -100.0% | Mumbai, Maharashtra, India | |||
| Vivaswan Pharmaceuticals Private Limited | ₹172 (FY 2020) | -99.0% | Pune, Maharashtra, India | |||
| Jamkas Pharmaceuticals Private Limited | ₹155 (FY 2023) | Panchkula, Haryana, India | ||||
| Karuna Trading and Pharmaceuticals Private Limited | ₹130 (FY 2025) | Kolkata, West Bengal, India | ||||
| Vizida Pharmaceuticals Private Limited | ₹100 (FY 2025) | -100.0% | Lucknow, Uttar Pradesh, India | |||
| Nautilus Pharmaceuticals Private Limited | ₹90 (FY 2025) | Thrissur, Kerala, India |
To see the full peer comparison of Kumbha Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Kumbha Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kumbha Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Kumbha Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCK1231D1Z0 | Maharashtra | Active | 31 Jul 2018 |
To see the full GST registrations and return filing status of Kumbha Pharmaceuticals Private Limited, buy the company report.
Recent activity
Kumbha Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Sharad Baburao Khaire was appointed as Director on 23 May 2018.
Frequently asked questions
Kumbha Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Kumbha Pharmaceuticals was a private limited company based in Mumbai, Maharashtra, India. The company worked in miscellaneous business activities, within the business services industry. It was incorporated on 23 May 2018 and is registered under CIN U74999MH2018PTC309816. The company has been struck off by the Registrar of Companies and is no longer operational.
Kumbha Pharmaceuticals had 2 directors:
- Sharad Baburao Khaire - Director
- Smita Santosh Dhumal - Director
The CIN (Corporate Identification Number) of Kumbha Pharmaceuticals is U74999MH2018PTC309816. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Kumbha Pharmaceuticals is at D 2403 Ashtavinayak Co – Op Hsg Soc Bldg 58D New Mhada Tower Opp Ekta Nagar, Mumbai, Maharashtra, India – 400067.
Kumbha Pharmaceuticals was incorporated on 23 May 2018. It is registered with the Registrar of Companies, Mumbai.
The latest financial statements of Kumbha Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Kumbha Pharmaceuticals is 27AAHCK1231D1Z0, registered in Maharashtra.
Kumbha Pharmaceuticals operated in the business services industry, in the miscellaneous business activities segment. It worked in this industry before it was struck off.
The peers of Kumbha Pharmaceuticals by revenue are Ziveli Pharmaceuticals Private Limited, Adiuvo Pharmaceuticals Private Limited, Everhale Pharmaceuticals Private Limited, Kalpshri Pharmaceuticals Private Limited, Benncare Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Sharad Baburao Khaire was appointed as Director on 23 May 2018. Smita Santosh Dhumal was appointed as Director on 23 May 2018.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
